@article{oai:nagasaki-u.repo.nii.ac.jp:00000169,
 author = {Ichikawa, Tatsuki and Miyaaki, Hisamitsu and Miuma, Satoshi and Motoyoshi, Yasuhide and Yamashima, Mio and Yamamichi, Shinobu and Koike, Makiko and Nakano, Yusuke and Honda, Tetsurou and Yajima, Hiroyuki and Uehara, Ryouhei and Miyazaki, Osamu and Kuribayashi, Yasutaka and Kira, Keiji and Taura, Naota and Nakao, Kazuhiko},
 issue = {21},
 journal = {Internal Medicine},
 month = {Nov},
 note = {Objective Patient-reported outcomes (PROs) are important measures of the quality of life (QOL) and symptoms in patients with hepatitis C virus (HCV). We evaluated the PROs at the beginning of direct-acting antiviral (DAA) treatment and three years later. A low QOL in patients with chronic 
liver disease suggested a low muscle mass. We compared the relationship between the QOL and muscle mass.Methods DAAs were administered to 100 patients with HCV infection. The PROs included the 
cirrhosis-related symptom score (CSS), presence of restless legs syndrome, Pittsburg sleep quality index (PSQI) to evaluate sleep disturbance, SF-36 to measure the QOL, and calculated body muscle mass (CBMM) measured at the beginning of treatment and three years later. Computed tomography (CT) was used to screen 
82 patients for hepatocellular carcinoma at the beginning of treatment and three years later. Cross-sectional CT images of the third lumbar vertebrae were analyzed to evaluate the body composition.Results The general health perception (GHN) of SF-36 was better at three years after DAA administration than at the beginning. Changes in the GHN (dGHN) were related to an improved sleep quality on the PSQI
 and CSS and increased CBMM. The dGHN was positively related to changes in the skeletal muscle. The sleep quality, sleep latency, fatigue, and abdominal fullness were related to dGHN. Conclusion The QOL is related to sleep disturbance and several other symptoms. Furthermore, in patients with an increased muscle volume after DAA treatment, increased muscle mass is associated with an improvement in the QOL., Internal medicine, 59(21), pp.2653-2660; 2020},
 pages = {2653--2660},
 title = {Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus},
 volume = {59},
 year = {2020}
}